Merck & Co., Inc. Restructuring Reserve
Merck & Co., Inc. (MRK) had Restructuring Reserve of $557.00 million as of 2025-03-31, per its 10-Q filed 2025-05-02.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2025-05-02
- 2025-03-31: Restructuring Reserve $557.00M.
- 2024-12-31: Restructuring Reserve $564.00M.
- 2024-09-30: Restructuring Reserve $651.00M.
- 2024-06-30: Restructuring Reserve $687.00M.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2025-03-31 | $557.00M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $564.00M 10-Q · filed 2025-05-02 | |
| 2024-09-30 | $651.00M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $687.00M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $736.00M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $712.00M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $567.00M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $577.00M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $506.00M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $513.00M 10-K · filed 2025-02-25 | |
| 2022-09-30 | $521.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $588.00M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $583.00M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $637.00M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $612.00M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $671.00M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $713.00M 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $586.00M 10-K · filed 2023-02-24 | $603.00M 10-K · filed 2021-02-25 |
| 2020-09-30 | $478.00M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $494.00M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $626.00M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $715.00M 10-K · filed 2022-02-25 | $759.00M 10-K · filed 2020-02-26 |
| 2019-09-30 | $667.00M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $543.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $583.00M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $534.00M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $573.00M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $590.00M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $651.00M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $747.00M 10-K · filed 2020-02-26 | |
| 2017-09-30 | $596.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $560.00M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $513.00M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $541.00M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $579.00M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $558.00M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $561.00M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $645.00M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $1.05B 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |